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Abstract Treatment of MCF-7 breast cancer cells with 50 nM 
okadaic acid triggers an apoptotic response which is accom-
panied by a 7-fold increase in the activity of a protein kinase with 
a relative molecular mass of 53 kDa. The activity of the kinase 
was stimulated by cell treatment with inhibitors of phosphopro-
tein phosphatase 1 and 2A, but not by stressing conditions. 
Okadaic acid-induced stimulation of the 53 kDa protein kinase 
was not abolished by coincubation of cells with cycloheximide. 
We conclude that stimulation of the 53 kDa protein kinase by 
inhibitors of phosphoprotein phosphatases involves pre-existing 
molecular components whose activity depends on the phospho-
rylation state of serine/threonine residues. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Protein phosphorylation represents a key molecular mech-
anism involved in the control of cell differentiation and pro-
liferation [1,2]. The role played by protein phosphorylation in 
cell death, instead, remains largely undetermined. 
The strategies devised to evaluate the role of phosphoryla-
tion of individual proteins in cell functioning often involve 
compounds which may alter either the kinase(s) responsible 
for the addition of phosphate to specific amino acid residues, 
or the phosphoprotein phosphatases catalyzing the opposite 
reaction. Okadaic acid (OA) is a biotoxin of algal origin [3] 
which binds with high affinity, and then inhibits phosphopro-
tein phosphatases (PP) 1 and 2A [2,4-6]. This toxin has been 
shown to induce apoptosis in several experimental systems, 
but the molecular events involved in the process have not 
been clarified yet [7-10]. 
In this report, we show that activation of a 53 k D a protein 
kinase accompanies breast cancer cell death induced by inhib-
itors of PP1 and PP2A. 
2. Materials and methods 
2.1. Materials 
Autoradiography films (Reflection), were purchased from DuPont 
NEN. [y-32P]ATP (>5000 Ci/mmol) was from Amersham. Tissue 
culture media and reagents were obtained from Life Technologies. 
Okadaic acid, calyculin A, and 1-Afar-okadaone were from Alexis 
Corporation (LC Laboratories). Prestained molecular mass markers 
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and myelin basic protein (MBP) were obtained from Sigma. All other 
reagents were of analytical grade. 
2.2. Cell culture conditions and treatments 
MCF-7 cells had been obtained from Istituto Zooprofilattico Spe-
rimentale della Lombardia e deU'Emilia (Brescia, Italy). Cells were 
grown in 5% carbon dioxide in air at 37°C, in 90 mm diameter Petri 
dishes, with a culture medium composed of Dulbecco's modified Eagle 
medium containing 1% nonessential amino acids and 10% foetal calf 
serum, as previously described [11]. 
Stock solutions (50 u.M) of okadaic acid, calyculin A, and l-Nor-
okadaone were prepared by dissolving the compounds in absolute 
ethanol, and were stored in glass vials protected from light at 
—20°C. Cell treatments were carried out using dishes near confluency 
and by addition of stock solutions of compounds directly to culture 
medium. Parallel dishes received vehicle to obtain control cell sam-
ples. 
The determination of cell density of individual samples was made 
by measuring the DNA content in total cell lysates, using the proce-
dure of Labarca and Paigen [12]. 
2.3. Fractionation of proteins by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis 
Cells were washed three times with 20 mM phosphate buffer, pH 
7.4. 0.15 M NaCl (PBS), and were lysed by dispersion in 20 mM 
phosphate buffer, pH 7.4, 0.15 M NaCl, 1% (v/v) NP-40, 0.5% (w/ 
v) sodium deoxycholate, 0.1% (w/v) SDS, 50 mM NaF, 10 mM 
Na/iP207, 0.1 mg/ml phenylmethylsulphonyl fluoride, 1 mM Na3VO,i, 
30 ug/ml aprotinin, and by two 10 s bursts of vortexing. Cytosoluble 
extracts were then obtained by centrifugation for 30 min at 16 000 X g. 
The supernatants of this centrifugation were then brought to 2% SDS 
and 5%i [S-mercaptoethanol, and proteins were fractionated by SDS-
PAGE according to Laemmli [13], using a 10%o separating gel and a 
3%o stacking gel. Molecular mass markers were: a2-macroglobulin 
subunit, 180 kDa; p-galactosidase subunit, 116 kDa; fructoses-phos-
phate kinase subunit, 84 kDa; pyruvate kinase subunit, 56 kDa; fu-
marase subunit, 48.5 kDa; lactic dehydrogenase subunit, 36.5 kDa; 
triosephosphate isomerase subunit, 26.6 kDa. 
2.4. In gel kinase assay 
Protein kinase activity after fractionation of proteins by SDS-
PAGE was detected by the procedure of Kameshita and Fujisawa 
[14], using separating gels including 0.1 mg myelin basic protein/ml 
gel. Phosphorylated proteins were detected by autoradiography of 
dried gels. When quantification of the 53 kDa protein kinase activity 
was carried out, portions of the dried gel corresponding to the 53 kDa 
band were excised, and were used for direct measurement of radio-
activity. The coefficients of variation of our estimates were lower than 
15%. 
3. Results and discussion 
Preliminary experiments were carried out to check the effect 
of OA in our experimental system, and we could confirm that 
OA treatment of MCF-7 cells leads to an apoptotic response 
[7,8], including a dose- and time-dependent inhibition of cell 
proliferation, which, as judged by thymidine incorporation, 
cell detachment from substratum, and measurements of cell 
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Fig. 1. In gel kinase assay of components from MCF-7 cells. Extracts were prepared from control cells (lanes 1 and 3) and cells which had 
been treated with 50 nM okadaic acid (lanes 2 and 4) for 24 h at 37°C. Equal amounts of protein were loaded onto each lane and were sepa-
rated by SDS-PAGE in gels containing no substrate (lanes 1 and 2) or 0.1 mg/ml myelin basic protein (lanes 3 and 4), before being renatured 
and used for assay of protein kinase activity, as described in Section 2. The positions of marker proteins running in parallel lanes have been in-
dicated. The exposure of lanes 1 and 2 was double than that of lanes 3 and 4, in order to allow visualization of the low levels of autophos-
phorylation of fractionated proteins, detectable in the absence of MBP. 
content of culture dishes, is maximal after a 24 h exposure to 
50 nM OA (not shown). OA has been also shown to activate 
mitogen activated protein kinase/extracellular signal regulated 
kinase (MAPK/ERK) isoforms in some experimental systems 
[9,15-18]. In the light of the fact that both p44 and p42 ERKs 
represent protein kinases involved in the control of cell pro-
liferation [19], we chose to use MCF-7 cell treatment for 24 h 
with 50 nM OA, to evaluate whether it might affect the ac-
tivity of p42/p44 ERKs. To this end we used an in gel kinase 
assay using myelin basic protein (MBP) as the substrate [14]. 
The results we obtained, showed that extracts prepared from 
both control and OA-treated cells contained protein kinase 
activities which could be measured when a suitable substrate 
(MBP) was included in the gel (Fig. 1). Under these condi-
tions, we found that MCF-7 cell treatment with OA induced 
only a marginal increase of p42/p44 ERK activity (Figs. 1 and 
3). As it is apparent from the data shown in Fig. IB, however, 
OA treatment of MCF-7 cells resulted in a net increase in the 
extent of phosphorylation of MBP by a protein kinase with a 
calculated molecular mass of 53 ±2.5 kDa (» = 10). 
We then determined the time-course of the OA-induced 
stimulation of MBP phosphorylation by in gel kinase assay, 
and the results of a typical experiment are shown in Fig. 2. 
Maximal levels of OA-induced stimulation of the 53 kDa 
protein kinase activity were detected after 12 h of MCF-7 
cell treatment with the toxin, and this stimulation was main-
tained in the next 12 h (Fig. 2). According to our estimates, 
the levels of the 53 kDa, OA-stimulated protein kinase (OSK) 
detected after a 24 h treatment of MCF-7 cells, were about 7-
fold (6.9 ± 1.0, n — 11) higher than those found in control cells. 
Cell treatment with OA has been shown to cause activation 
of a 55 kDa protein kinase [20], which is a member of the c-
Jun NH2-terminal kinase/stress-activated protein kinase fam-
ily (JNK/SAPK, Refs. [21-23]). Although MBP does not rep-
resent a good substrate for these kinases, as assessed by in gel 
kinase assay [20-22], we thought it was important to ascertain 
whether OSK might represent some particular isoform of 
SAPK. To this end, we compared MBP phosphorylation, us-
ing extracts prepared from MCF-7 cells which had been either 
treated with OA, or subjected to classical stressing conditions, 
such as heat shock and inhibition of protein synthesis [21,23]. 
The results we obtained (Fig. 3), showed that increased 53 
kDa kinase activity could be detected after OA, but not 
heat (lane 3) or cycloheximide (lane 4) treatment of MCF-7 
cells. 
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Fig. 2. Time-course of the effect of okadaic acid on the activity of 
the 53 kDa protein kinase obtained from MCF-7 cells. (A) Cells 
were treated with 50 nM OA for 0 (lane 1), 1 (lane 2), 2 (lane 3), 
4 (lane 4), 6 (lane 5), 12 (lane 6), 18 (lane 7), and 24 (lane 8) h at 
37°C, before being used to prepare cell extracts. Equal amounts of 
protein were fractionated by SDS-PAGE with a separating gel con-
taining MBP, and the gel was used for in gel kinase assay and auto-
radiography, as described in Section 2. The electrophoretic mobility 
of pre-stained fumarase marker (48.5 kDa) running in a parallel 
lane has been indicated. (B) The bands corresponding to the 53 
kDa protein kinase of the gel shown in (A) were excised and used 
for direct measurement of the radioactivity incorporated in the 
MBP substrate. 
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Fig. 3. Effect of MCF-7 cell stimulation by stressing conditions on 
the levels of 53 kDa protein kinase activity. Cells were treated with 
either 50 nM OA (lane 2), or 1 mM cycloheximide (lane 4), or ve-
hicle (lanes 1 and 3) for either 24 h at 37°C (lanes 1, 2, and 4), or 
1 h at 43°C (lane 3), before being used to prepare cells extracts, 
which were fractionated by SDS-PAGE with a separating gel con-
taining MBP. At the end of electrophoresis, the gel was used for in 
gel kinase assay, as described in Section 2. The positions of marker 
proteins running in a parallel lane have been indicated. 
These results prompted us to check whether increased 53 
kDa kinase activity could be selectively triggered by inhibitors 
of serine/threonine phosphoprotein phosphatases. MCF-7 
cells were then treated with either OA or calyculin A, or 
with 1-iVor-okadaone, which is an inactive metabolite of OA 
[24], and the 53 kDa kinase activity was determined by in gel 
kinase assay. As it is shown in Fig. 4, only OA and calyculin 
A, which are potent inhibitors of PP1 and PP2A [2,4-6] could 
cause enhancement of MBP phosphorylation by the 53 kDa 
kinase, indicating that high levels of OSK activity depend on 
maintenance of some component(s) in a phosphorylated state. 
If the time-course of OA stimulation of the 53 kDa protein 
kinase is considered (Fig. 2), the 10-12 h needed to reach 
maximal levels of activity pose the question on whether the 
phenomenon might represent a secondary response involving 
neosynthesis of components mediating the effect of OA. We 
then ascertained whether OA stimulation of the 53 kDa pro-
tein kinase could be also observed under conditions in which 
protein synthesis is inhibited by at least 95% [25]. The results 
we obtained (Figs. 3 and 5), showed that a 24 h treatment of 
MCF-7 cells with 1 mM cycloheximide could depress OSK 
activity detectable in extracts from both control and OA-
treated cells by about 40%, but the stimulation of the 53 
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Fig. 4. Effect of MCF-7 cell treatment with inhibitors of serine/ 
threonine phosphoprotein phosphatases on the levels of 53 kDa pro-
tein kinase activity. Cells were treated for 24 h at 37°C with either 
50 nM OA (lane 2), 50 nM l-Nor-okadaone (lane 3), 5 nM calycu-
lin A (lane 4), or vehicle (lane 1), before being used to prepare cell 
extracts, which were fractionated by SDS-PAGE with a separating 
gel containing MBP. At the end of electrophoresis, the gel was used 
for in gel kinase assay, as described in Section 2. The electrophoret-
ic mobility of pre-stained fumarase (48.5 kDa) marker running in a 
parallel lane has been indicated. These results have been taken from 
one experiment, and are representative of those obtained in the two 
separate experiments we have prerformed. 
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Fig. 5. Effect of inhibition of protein synthesis on the stimulation of 
53 kDa protein kinase activity caused by okadaic acid. MCF-7 cells 
were treated for 24 h at 37°C with either 50 nM OA (lanes 2 and 
4), or vehicle (lanes 1 and 3), and in the presence (lanes 3 and 4), 
or in the absence (lanes 1 and 2) of 1 mM cycloheximide, before 
being used to prepare cell extracts, which were fractionated by SDS-
PAGE with a separating gel containing MBP. At the end of electro-
phoresis, the gel was used for in gel kinase assay, as described in 
Section 2. The electrophoretic mobility of pre-stained fumarase 
(48.5 kDa) marker running in a parallel lane has been indicated. 
These results have been taken from one experiment, and are repre-
sentative of those obtained in the three separate experiments we 
have performed. 
kDa kinase activity due to OA was not prevented by blocking 
protein synthesis, under our experimental conditions (Fig. 5). 
Furthermore, the same levels of OSK activity were detected in 
the extracts prepared from cells which had, or had not, been 
treated with cycloheximide during shorter (8-12 h) incuba-
tions with OA (not shown). On the basis of these findings, 
therefore, it can be concluded that the increase of the 53 kDa 
protein kinase activity induced by inhibitors of serine/threo-
nine phosphoprotein phosphatases, involves preexisting com-
ponents, whose functioning is controlled by the phosphoryla-
tion state of serine/threonine residues which are themselves 
substrates of PP1 or PP2A. 
Indeed, the 53 kDa protein kinase we have detected might 
itself represent a substrate of PP1 and/or PP2A. This inter-
pretation, however, can be directly tested after OSK will be 
available in a pure form. Experiments are in progress to 
achieve this goal, which will also lead to identification of 
OSK. In any case, the information available so far allow a 
preliminary comparative evaluation among protein kinases 
sharing properties with the 53 kDa kinase we have detected. 
The molecular mass of OSK, for instance, would indicate that 
it should not represent one of the protein kinases known to be 
involved in the control of cell proliferation, and being capable 
to use MBP as the substrate, such as protein kinase C [26] and 
MAPK [19,27] isoforms. It seems also unlikely that OSK 
might represent calmodulin dependent protein kinase II, 
which can use MBP as the substrate in the kinase assay we 
have employed in this study [14]. Inclusion of 0.15 mM CaCb 
and 10 (J,g/ml calmodulin to the mixtures used in our assay, in 
fact, did not alter the extent of OSK activity detectable in the 
samples prepared from both control and OA-treated cells (not 
shown). Furthermore, the property to efficiently use MBP as 
the substrate, and the lack of activation by heat shock and 
cycloheximide, would also indicate that OSK should not rep-
resent an isoform of the JNK/SAPK family [21-23]. 
On the basis of the fact that maximal activation of the 53 
kDa protein kinase accompanies the apoptotic response of 
MCF-7 cells to OA treatment, our working hypothesis is 
that OSK may represent a functional homologue of stress-
activated protein kinases. In any case, the identification and 
a more complete characterization of OSK should be pursued, 
as its activation accompanies death of breast cancer cells, and 
then this 53 kDa protein kinase may become a relevant mo-
lecular target of therapeutical intervention. 
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